Fund Details
Overview
Investment portfolio
104rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
Expedition Therapeutics | Aug 2026Participated | $115 MSeries B | |
Serapha Bio | Jun 2026Participated | $138 MSeries A | |
ADCendo | Apr 2026Participated | $76 MSeries C | |
Beacon Biosignals | Apr 2026Participated | $11 MSeries B | |
Pinnacle Medicines | Mar 2026Participated | $89 MSeries B | |
Angitia Biopharmaceuticals | Feb 2026Participated | $130 MSeries D | |
Mirador Therapeutics | Jan 2026Participated | $250 MSeries B | |
Diagonal Therapeutics | Jan 2026Participated | $125 MSeries B | |
Beacon Biosignals | Nov 2025Participated | $86 MSeries B | |
Expedition Therapeutics | Oct 2025Participated | $165 MSeries A | |
Verdiva Bio | Jan 2025Participated | $411 MSeries A | |
Aviceda Therapeutics | Jan 2025Participated | $208 MSeries C | |
Expedition Therapeutics | Aug 2026Participated | $115 MSeries B | |
Serapha Bio | Jun 2026Participated | $138 MSeries A | |
ADCendo | Apr 2026Participated | $76 MSeries C | |
Beacon Biosignals | Apr 2026Participated | $11 MSeries B | |
Pinnacle Medicines | Mar 2026Participated | $89 MSeries B | |
Angitia Biopharmaceuticals | Feb 2026Participated | $130 MSeries D | |
Mirador Therapeutics | Jan 2026Participated | $250 MSeries B | |
Diagonal Therapeutics | Jan 2026Participated | $125 MSeries B | |
Beacon Biosignals | Nov 2025Participated | $86 MSeries B | |
Expedition Therapeutics | Oct 2025Participated | $165 MSeries A | |
Verdiva Bio | Jan 2025Participated | $411 MSeries A | |
Aviceda Therapeutics | Jan 2025Participated | $208 MSeries C |
104 Items
104
Items
...
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 1 | 16 |
| Series B | 3 | 47 |
| Series C+ | 1 | 24 |
| Other Equity | 0 | 12 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Sep '19 | 3 |
| Oct '19 | 0 |
| Nov '19 | 1 |
| Dec '19 | 1 |
| Jan '20 | 1 |
| Feb '20 | 1 |
| Mar '20 | 1 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 2 |
| Jul '20 | 5 |
| Aug '20 | 2 |
| Sep '20 | 1 |
| Oct '20 | 4 |
| Nov '20 | 0 |
| Dec '20 | 4 |
| Jan '21 | 8 |
| Feb '21 | 3 |
| Mar '21 | 5 |
| Apr '21 | 5 |
| May '21 | 4 |
| Jun '21 | 1 |
| Jul '21 | 2 |
| Aug '21 | 3 |
| Sep '21 | 8 |
| Oct '21 | 3 |
| Nov '21 | 1 |
| Dec '21 | 2 |
| Jan '22 | 2 |
| Feb '22 | 1 |
| Mar '22 | 0 |
| Apr '22 | 1 |
| May '22 | 0 |
| Jun '22 | 1 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 1 |
| Nov '22 | 0 |
| Dec '22 | 1 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 1 |
| Jun '23 | 0 |
| Jul '23 | 1 |
| Aug '23 | 2 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 2 |
| Mar '24 | 1 |
| Apr '24 | 1 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 2 |
| Aug '24 | 0 |
| Sep '24 | 1 |
| Oct '24 | 0 |
| Nov '24 | 1 |
| Dec '24 | 1 |
| Jan '25 | 2 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 1 |
| Nov '25 | 1 |
| Dec '25 | 0 |
| Jan '26 | 2 |
| Feb '26 | 1 |
| Mar '26 | 1 |
| Apr '26 | 2 |
| May '26 | 0 |
| Jun '26 | 1 |
| Jul '26 | 0 |
| Aug '26 | 1 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 103 |
| Hardware & Robotics | 3 |
| AI & Machine Learning | 2 |
| Professional Services | 2 |
| Space & Frontier Tech | 1 |
| Consumer & Lifestyle | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 2 |
| $25M-$50M | 7 |
| $50M-$100M | 27 |
| $100M-$250M | 60 |
| $250M-$500M | 8 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 4 of 4 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 95 |
| Europe | 5 |
| China | 3 |
| Canada | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Surveyor Capital | 50 |
| Janus Henderson Investors | 47 |
| RA Capital Management | 41 |
| Cormorant Asset Management | 34 |
| OrbiMed | 34 |
| BVF Partners | 26 |
| Venrock | 23 |
| Wellington Management | 22 |
| Boxer Capital | 18 |
| T. Rowe Price Associates | 18 |
| Casdin Capital | 16 |
| Samsara BioCapital | 16 |
| Perceptive Advisors | 15 |
| Fidelity Management & Research Company | 14 |
| Foresite Capital | 14 |
| RTW Investments | 14 |
| Vivo Capital | 14 |
| Farallon Capital Management | 13 |
| Invus | 13 |
| Redmile Group | 13 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 5 | 5% |
| Participating | 99 | 95% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 2 | 40% |
| Co-led | 3 | 60% |
Team
Graham Walmsley
Co-Founder and Managing Member